Gene Editing Market Growth Prospects, Key Vendors, Future Scenario Forecast to 2032

1
Gene Editing Market with Report In Depth Industry
Analysis on Trends, Growth, Opportunities and
Forecast till 2032
2

• Industry Insights

• The gene editing market is projected to grow
  massively by 2030 owing to rising demand for gene
  synthesis and CRISPR technologies. In addition,
  technological advancements, coupled with growing
  investment in RD activities, are speculated to
  further propel market growth through the forecast
  timespan.
• Recently, the COVID-19 pandemic has impacted the
  market positively as gene editing technologies
  allow the detection of SARS-CoV-2 and the
  alteration of defected genes in plants and
  animals. Prominent technological advancements in
  the market have positively influenced the overall
  product landscape.
• Recently, in May 2022, a Nature Nanotechnology
  study aimed to enhance CRISPR/Cas9 gene editing
  by modulating cellular mechanical properties for
  the treatment of cancer.
• It concluded that modulating the stiffness of the
  tumor tissue can help in improving gene editing
  in tumors, offering a new strategy for cancer
  treatment with gene editing.

3

• Moreover, government initiatives to encourage
  research and development activities for the
  treatment of genetic disorders have fueled gene
  editing market growth. For instance, in May 2022,
  the U.S. Food and Drug Administration (FDA)
  awarded fast-track designation to biotech firm
  Graphite Bio's GPH101, a gene editing therapy
  that has been developed to correct genetic
  mutation caused by sickle cell disease.
• Furthermore, key participants in the industry
  have been focusing on technological innovation in
  gene editing therapies, along with effective
  growth strategies, to prosper in the market. To
  quote an instance, in May 2022, U.S. FDA granted
  Orphan Drug Designation to EDIT-301, an
  experimental gene editing therapy by
  clinical-stage biotech company Editas Medicine to
  treat beta thalassemia.
• The gene editing market has been bifurcated based
  on end-user, application, technology, and region.
  In terms of application, the market has been
  categorized into animal genetic engineering,
  plant genetic engineering, cell line engineering,
  and others. The cell line engineering segment is
  slated to expand at a CAGR of more than 15.3
  through the forecast period due to the widespread
  application of cell line engineering.

4

• Regional Analysis

• In the regional frame of reference, the Latin
  America gene editing market accounted for over
  11.1 of the overall industry revenue in 2021.
  This growth is attributed to mounting incidences
  of genetic disorders across several countries in
  the LATAM region.

• Competitive Analysis

• Bearn Therapeutics
• Thermo Fisher Scientific Inc.
• Intellia Therapeutics, Inc.
• CRISPR Therapeutics
• Caribou Biosciences, Inc

5
Gene Editing Market _at_ https//www.gminsights.com/i
ndustry-analysis/gene-editing-market
Request for sample of this research report _at_
https//www.gminsights.com/request-sample/detail/8
10
Request for customization _at_ https//www.gminsights
.com/roc/810
6
Stay In Touch Social Media
7
THANK YOU
www.gminsights.com